Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15555967 | 0.89 | LMNA (0.69) | TDP1NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL745476 | 0.87 | LMNA (0.62) | TDP1NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL28118444 | 0.87 | TDP1 (0.72) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL275850 | 0.84 | TDP1 (0.64) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL451184 | 0.84 | TDP1 (0.68) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL22832718 | 0.84 | TDP1 (0.81) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL4485687 | 0.83 | TDP1 (0.62) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL9367557 | 0.82 | TDP1 (0.92) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL6025448 | 0.82 | TDP1 (0.66) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL8890081 | 0.82 | TDP1 (0.66) | TDP1NPC1RAB9AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114072486-B | Alkaline ashless additive and lubricating composition containing said additive | 路博润公司 | 2023-06-09 | — | — | CN | claimed |
| CN-116425754-A | Aromatic heterobicyclic compounds and antiviral uses thereof | 苏州爱科百发生物医药技术有限公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2022025204-A1 | TREATMENT OF DISEASE WITH EPOR ANTAGONIST | エポメッド株式会社 | 2022-02-03 | — | — | WO | disclosed |
| US-11040939-B1 | N-transfer reagent and method for preparing the same and its application | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2021-06-22 | — | — | US | disclosed |
| EP-3229610-B1 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020054813-A1 | ANTI-ERYTHROPOIETIN RECEPTOR PEPTIDE | エポメッド株式会社 | 2020-03-19 | — | — | WO | disclosed |
| WO-2011066869-A1 | BETA-HAIRPIN PEPTIDOMIMETICS | POLYPHOR AG (CH) | 2011-06-09 | — | — | WO | disclosed |
| US-5580896-A | Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives | WARNER-LAMBERT COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0148883-A1 | ALLOPURINOL PRODRUGS. | GEA AS (DK) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000368-A1 | ALLOPURINOL PRODRUGS | A/S GEA (DK) | 1985-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11040939-B1 | N-transfer reagent and method for preparing the same and its application | DNTT, NNMT, NMT1 | TDP1 1698/4885NPC1 699/4885RAB9A 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.